Pfizer Inc
NYSE: PFE
$25.65
+$0.52 (+2.1%)
Closing Price on November 22, 2024
PFE Articles
24/7 Wall St. has conducted a review of the top dividends from America’s largest companies. There were 25 such companies paying a yield of 3.5% or more — and some much higher.
Published:
Last Updated:
These are the top 20 stock buybacks in dollars spent during the first quarter of 2017 of all S&P 500 companies.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Cisco, United Technologies, Pfizer, and Merck led the DJIA lower Monday.
Published:
Last Updated:
The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) runs from June 2 to June 6. The following companies have signaled that they will be presenting data, or data will be...
Published:
Last Updated:
A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow they have for the rest of 2017.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly upward.
Published:
Last Updated:
These are the top 10 Sell equivalent ratings seen from analysts during the week of May 15 to May 19, 2017 -- plus a bonus that may as well have been a downgrade to Sell.
Published:
Last Updated:
UnitedHealth, Nike, Pfizer, and Wal-Mart led the DJIA to a modest decline Tuesday.
Published:
Last Updated:
The the top analyst upgrades, downgrades and other research calls from Tuesday include AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy and Yum Brands.
Published:
Last Updated:
Credit Suisse provided its outlook for several large-cap pharmaceutical stocks Monday morning. The analyst has three top picks to consider.
Published:
Last Updated:
With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag.
Published:
Last Updated:
Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.
Published:
Last Updated:
The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly downward.
Published:
Last Updated:
Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated: